Oscar Brunetto *

Autor invitado por SIIC

Revision acerca de la comprension de los mecanismos involucrados en la adquisisioin de una masa ósea adecuada y de los factores o enfermedades que pueden interferir con ese proceso

OSTEOPOROSIS EN PACIENTES PEDIATRICOS

Revisión acerca de los conceptos relacionados con la adquisición de la masa ósea adulta y el conocimiento de los factores o enfermedades que pueden afectar la ganancia normal de masa ósea. Se describen aquellas enfermedades que pueden producir una masa ósea disminuida en edad pediátrica y por último se contemplan aspectos terapéuticos

*Oscar Brunetto
describe para SIIC los aspectos relevantes de su trabajo
OSTEOPOROSIS EN PEDIATRÍA
Institución principal de la investigación
*Hospital de Niños Pedro de Elizalde, Buenos Aires, Argentina
Imprimir nota

Comprar este artículo
Otros artículos escogidos

Referencias bibliográficas
Davies JH, Evans BA, Gregory JW. Bone mass adquisition in healthy children. Arch Dis Child doi:101136, 2005
Osteoporosis prevention, diagnosis, and therapy. NIH Consens Statement 2000, March 27-29; 17(1):1-36.
Soyka LA, Fairfield WA, Klibanski A. Hormonals determinants and disorders of peak bone mass in children. J Clin Endocrinol Metab 2001; 85:3951-3963.
Ferretti JL. Regulación biomecánica y modulación endocrinometabólica de la eficiencia estructural ósea. En Osteoporosis (1a. edición). Zanchetta JR. Editorial Interamericana, Argentina, pp.73-97.
Goulding A, Jones I, Williams S, Grant A, Taylor R, Manning P, Langley J. First fracture is associated with incresed risk of new fractures during growth. J Pediatr 2005; 146:286-8.
Goulding A, Jones I, Taylor R, Manning P, Williams S. More broken bones:a 4 year double cohort study of young girls with or without distal forearms fractures. J Bone Min Res 2000; 15;2011-2018.
Burnham J, Leonard MB. Bone disease in pediatric rheumatologic disorders. Current Rheumatologic Report 2004; 6:70-78.
Saggese G, Baroncelli G, Bertelloni S. Osteoporosis in children amd adolescent: Diagnosis, risk factors and prevention. Journal of Pediatric Endocrinology and Metabolism 2001; 14:833-859.
Ellis K, Shypailo R, Hardin D, Perez M, Motil K, Wong W, Abrahams S. Z score prediction model for assessment of bone mineral content in pediatric diseases. J Bone Miner Res 2001; 16(9):1658-64.
Ward L, Glorieux F. Osteoporosis in children. En: Pediatric Bone (First edition). Glorieux FH, Pettifor J, Juppner H. Academic Press, USA, pp. 401-442.
Rauch F, Glorieux F. Osteogénesis imperfecta: Lancet 2004; 363:1377-85.
Glorieux F, Rauch F, Plotkin H, Travers R, Roughley P, Lalic L, Glorieux D, Fassier F, Bishop N. Type V osteogenesis imperfecta: A new form of brittle bone disease. J Bone Miner Res 15(9):1650-1658.
Glorieux F, Ward L, Rauch F, Lalic L, Roughley P, Travers R. Osteogenesis imperfecta type VI: A form of brittle bone disease with mineralization defect. J Bone Miner Res 2002; 17:30-38.
Ward L, Rauch F, Travers R, Chabot G, Azouz EM, Lalic L, Roughley P, Glorieux F. Osteogenesis imperfecta Type VII: an autosomal recessive form of brittle bone disease. Bone 2002; 31:12-18.
Glorieux F, Bishop N, Plotkin H, Chabot G, Lanoue G, Travers R. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta.N Engl J Med 1998; 339:947-52.
Daci E, Van Cromphaut S, Bouillion R. Mecanism influencing bone metabolism in chronic illness. Horm Res 2002; 58(suppl1):44-51.
Abrams S, O'Brien K. Calcium and bone mineral metabolism in children with chronic illnesses.
Annu Rev Med 2004; 13-32.
Kavak US, Salvatore S, Salvatori A. Bone mineralization and body composition in youg patients with celiac disease: J Pediatr Gastroenterol Nutr 2003; 37:434-6.
Harpavat M, Keljo D, Regueiro M. Metabolic bone disease in inflamatory bone disease. J Clin Gastroenterol 2004; 38(3):218-224.
Gokhale R, Favus MJ, Karrison T. Bone mineral density assessment in children with inflamatory bowel disease. Gastroenterology 1998; 114:902-911.
Mora S, Barrera G. Bone mass and bone metabolism in pediatric gastrointestinal disorders. J Pediatr Gastroenterol Nutr 2004; 39:129-140.
Kotaniemi A, Savolainen A, Kroser H, Kautiainen H, Isomaki H. Weight bearing activity,calcium intake, sistemic glucocorticoid, chronic inflamation and body constitution as determinant of lumbar and femoral bone mineral in juvenile chronic arthritis.Sacand J Rheumatol 1999; 28:19-26.
Cohen D, Adachi J. The treatment of glucocorticoid induces osteoporosis. Journal of Steroid Biochemistry and Molecular Biology 2004; 88:337-349.
Bianchi ML. Glucocorticoid and bone: some general remarks and some special observations in pediatric patients. Calcif Tissue Int 2002; 70:384-390.
Bianchi ML, Cimaz R, Bardare R. Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse conective tissue diseases in children. Arthritis Rheum 2000; 43:1960-6.
Rudge S, Hallwood A, Horne A, Lucas J, Wu F, Cundy T. Effects of once weekly oral alendronate on bone in children on glucocorticoid treatment. Rheumatology on line doi 10.1093, 2005.
Accot P, Wong J, Lang B, Crocker J. Pamidronate treatment of pediatric fracture patients on chonic steroid theraphy. Pediatr Nephrol 2005; 20:368-373.
Noguera A, Ros J, Pavia C, Alcover E, Valls C, Villalonga M. Bisphosphonates, a new treatment for glucocorticoid induced osteoporosis in children. J Pediatr Endocrinol Metab 2003; 16:529-536.
Apkon S. Osteoporosis in children who have disabilities. Phys Med Rehabil Clin N Am 2002; 13:839-855.
Zacharin M. Current avdvances in bone health of disabled children. Curr Opin Pediatr 2004; 16:545-551.
Henderson R, Lark R, Kacskemethy H, Miller F, Harcke T, Bachrach S. Bisphosphonates to treat osteopenia in children with quadriplejic cerebral palsy: a randomized placebo-controled trial. J Pediatr 2002; 141:644-51.
Sholas M, Tann B, Gaebler-Spira D. Oral bisphosphonates to treat disuse osteopenia in children with disabilities. J Pediatr Orthop 2005; 25:326-331.
Lanou A, Berkow S, Barnard N. Calcium, dairy products and bone health in children and young adults: a reevaluation of the evidence. Pediatrics 2005; 115(3):736-743.
Fulkerson J, Himes J, French S, Jensen S. Bone outcomes and technical measurement issues of bone health, among children and adolescents: Considerations for nutrition and physical activity intervention trials. Osteoporos Int 2004; 15:929-941.

Otros artículos de Oscar Brunetto

Brunetto O, Tau C, Cudeiro P. Tratamiento con pamidronato endovenoso cíclico en pacientes afectados de osteogénesis imperfecta severa. Rev Argent Endocrinol Metab 2005; 42(5):143.
Brunetto O, Yáñez A, Cudeiro P, Tripodi J, Arias Cau AC, Insua C. Vitamin D levels in children with cerebral palsy. J Pediatr Endocrinol Metab 2006; 19(supl.3):1077.
Brunetto O, Arias Cau AC, Insua C. Convulsiones por hipocalcemia en un paciente portador de deficiencia de vitamina D secundaria a déficit materno. Arch Argent Pediatr 2006; 104(5):431-434.
Brunetto O, Yáñez A, Cudeiro P, Arias Cau AC, Insua C. Bone and mineral metabolism in children with myelomenigocele. Hormone Research 2005; 64(S1):95.

Para comunicarse con Oscar Brunetto mencionar a SIIC como referencia:
obrunetto@fibertel.com.ar

---

Acerca del trabajo completo

OSTEOPOROSIS EN PACIENTES PEDIATRICOS

Título original en castellano
OSTEOPOROSIS EN PEDIATRIA

Autor


Acceso a la fuente original
Revista Argentina de Endocrinología y Metabolismo
http://www.raem.org.ar/

El artículo se relaciona estrictamente con las especialidades de siicsalud
El artículo se conecta secundariamente con las especialidades